‘Transformative’ HIV PrEP shot slowly overcomes cost hurdles

HIV/AIDS activists heralded the approval of a new twice-yearly pre-exposure prophylaxis (PrEP) medication last year, but ...
The New England Journal of Medicine

Long-Acting HIV Medicines and the Pandemic Inequality Cycle — Rethinking Access

The world may look back on 2024 as a pivotal time in the fight against AIDS — the start of a revolution in the global biomedical response to HIV using long-acting antiretroviral medicines. Young women ...
Bhekisisa

The anti-HIV jab Buhle trusts — and 456 000 South Africans can soon get for free

For the past three years, Buhle Sikade, 22, has been using an injection that gives her almost foolproof protection against ...
Forbes

The Beginning Of HIV’s End: Innovative Technologies Changing HIV Care

I came of age during the height of the AIDS crisis in the '90s. I was just starting my career in the pharmaceutical industry as the epidemic hit its peak, and the anxiety and concern surrounding it ...